NCT Number: NCT00349570
Xtract™ Aspiration Catheter Registry Study
Intra-coronary thrombosis and thromboembolism continues to be a challenge for percutaneous coronary and other vascular interventional techniques. The Xtract™ Aspiration Catheter is a single use device designed to remove fresh, soft emboli and thrombi from the arterial system using standard catheter techniques, compatible with 6 Fr guide catheters and 0.014 guidewires. The purpose of this registry study is to validate the design and demonstrate the performance of the Xtract Aspiration Catheter as a thrombectomy catheter during percutaneous intervention of vessels in the arterial system. Subjects will be enrolled during percutaneous intervention when the Interventional Physician decides a thrombectomy catheter is needed to remove thrombus during the procedure.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Auckland City Hospital, Auckland, New Zealand
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Planned percutaneous intervention to a native coronary, coronary vein graft, renal artery or carotid artery lesion
- Angiographic evidence of thrombus.
Treatment and study plan
Primary outcomes
-
The primary objective of the study will be to evaluate the performance of the Xtract Aspiration Catheter.
Sponsors and collaborators
Lead sponsor
Lumen Biomedical
Industry
Registry information
Important dates
- Study start
- 2006
- Study completion
- 2008
- First posted
- Jul 7, 2006
- Registry last updated
- Oct 21, 2008
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
CES1 Crossover Trial of Clopidogrel and Ticagrelor
NCT03161678
Cardiovascular Diseases, Embolism and Thrombosis
Lancaster, Pennsylvania, United States
View Trial DetailsDIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
NCT06095518
Cardiovascular Diseases, Embolism and Thrombosis
Hong Kong
View Trial DetailsPersonalized Medicine Decision-Making in a Virtual Clinical Setting
NCT02108041
Blood Clots, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial DetailsThe Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
NCT05009862
Arterial Occlusive Diseases, Arteriosclerosis
Nashville, Tennessee, United States
View Trial Details